Proteolytic inactivation of plasma C1- inhibitor in sepsis.
Open Access
- 1 August 1989
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 84 (2) , 443-450
- https://doi.org/10.1172/jci114185
Abstract
Activation of both the complement system and the contact system of intrinsic coagulation is implicated in the pathophysiology of sepsis. Because C1 inhibitor (C1-Inh) regulates the activation of both cascade systems, we studied the characteristics of plasma C1-Inh in 48 patients with severe sepsis on admission to the Intensive Care Unit at the Free University of Amsterdam. The ratio between the level of functional and antigenic C1-Inh (functional index) was significantly reduced in the patients with sepsis compared with healthy volunteers (P = 0.004). The assessment of modified (cleaved), inactive C1-Inh (iC1-Inh), and complexed forms of C1-Inh (nonfunctional C1-Inh species) revealed that the reduced functional index was mainly due to the presence of iC1-Inh. On SDS-PAGE, iC1-Inh species migrated with a lower apparent molecular weight (Mr 98,000, 91,000, and 86,000) than native C1-Inh (Mr 110,000). Elevated iC1-Inh levels (greater than or equal to 0.13 microM) were found in 81% of all patients, sometimes up to 1.6 microM. Levels of iC1-Inh on admission appeared to be of prognostic value: iC1-Inh was higher in 27 patients who died than in 21 patients who survived (P = 0.003). The mortality in 15 patients with iC1-Inh levels up to 0.2 microM was 27%, but in 12 patients with plasma iC1-Inh exceeding 0.44 microM, the mortality was 83%. The overall mortality in the patients with sepsis was 56%. We propose that the cleavage of C1-Inh in patients with sepsis reflects processes that play a major role in the development of fatal complications during sepsis.This publication has 62 references indexed in Scilit:
- The role of cachectin/TNF in endotoxic shock and cachexiaImmunology Today, 1988
- Inhibition of human blood coagulation factor XIa by C.hivin.1 inhibitorBiochemistry, 1988
- Participation and interactions of neutrophil elastase in haemostatic disorders of patients with severe infectionsEuropean Journal of Haematology, 1987
- Activation and Inhibition of Hageman Factor-Dependent Pathways and the Complement System in Uncomplicated Bacteremia or Bacterial ShockThe Journal of Infectious Diseases, 1985
- Enzymatic inactivation of human plasma C-inhibitor and α1-antichymotrypsin by pseudomonas aeruginosa proteinase and elastaseBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1984
- Prekallikrein Activation and High-Molecular-Weight Kininogen Consumption in Hereditary AngioedemaNew England Journal of Medicine, 1983
- Complement-Induced Granulocyte AggregationNew England Journal of Medicine, 1980
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Interaction of 125I‐labelled complement subcomponents Cr and Cs with protease inhibitors in plasmaFEBS Letters, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970